HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
Vismodegib
Description
Vismodegib inhibits the hedgehog signalling pathway and is indicated for treatment of adult basal cell carcinoma. FDA approved on Jan 30, 2012.
No brand information found.
